ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Clinical trial NCT06373731 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06373731
- Sponsor
- Stealth BioTherapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2027-08-01
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.